Search results for: 'analyz'

This research service analyzes the market for clinical laboratory analyzers within the United States. The United States market was divided into the clinical chemistry, immunoassay, integrated, hematology, hemostasis, and blood gas analyzer market segments. Each segment of this service covers market drivers, market restraints, competitive structur...

This research study examines the hearing instruments and ABR and OAE analyzers markets in the U.S. in 2005. The objective of this study is to evaluate the present state of these markets and present a forecast and analysis of the units, pricing and revenues. The forecast period is from 2006 to 2012, with a base year of 2005. The segment also identi...

This research service analyzes and provides forecasts of the US hematology diagnostics market from 2012 to 2017. The market is broadly classified into 2 major segments: analyzers and reagents. The US hematology market was sized using a bottom-up revenue model developed from the actual installed base of hematology analyzers in US laboratories, the d...

The United States healthcare industry generates vast amounts of data, offering immense opportunities for exchange and monetization. However, the fragmented nature of the industry and the sensitive nature of healthcare data create unique challenges. This report analyzes the US healthcare data exchange and monetization landscape, focusing on key ...

This research service analyzes the market for ECG and Cardiac Monitoring products and services within the United States. Product markets assessed included Resting ECG Products, Stress Testing Systems, ECG Data Management Systems, Holter Monitor Systems, and Cardiac Event Monitoring Systems. Services markets assessed included Point-of-Care ECG Ser...

This research service analyzes key data and provides an in-depth analysis of the US cardiac ablation market. The segments covered include catheter ablation, surgical ablation, and cardiac mapping. The major topics explored in this study include the most significant products marketed by top participants, cost analysis, competitive playbook, regulato...

The overall research objective was to capture and analyze global next-generation (NGS) sequencing trends and use. Most researchers outsource NGS technologies; however, in-house NGS technology use is expected to increase within the next 12 months. Data accuracy and operating costs are the top criteria for purchasing sequencing instruments. Disease-r...

The immunoassay and clinical chemistry market is the highest share contributor for the total in vitro diagnostics (IVD) market. Globally valued at $28.7 billion in 2019, this market segment contributes 37.6% of the total IVD market of $76.3 billion. Within the high-medium to low analyzer segment, there are over 40 companies globally. Of these, 14 c...

This research service analyzes the U.S. neurostimulation market from 2003 to 2013.